The clinical significance of osteoporosis lies in the fractures which occur, and the most important fracture is hip fracture. According to the WHO criteria, T-score is defined as: (BMD patient -BMD young normal mean )/SD young normal population , where BMD is bone mineral density and SD is the standard deviation. In adult women, the cutpoint value of patient BMD 2.5 SD below BMD young normal mean satisfies that, when the femoral neck is measured, osteoporosis prevalence is about 16.2% for those aged ≥50 years, the same as the lifetime risk of hip fragility fracture (FF) (1,2). If other sites are also considered, this cutpoint value identifies approximately 30% of postmenopausal women as having osteoporosis, which is approximately equivalent to the lifetime risk of FF at the spine, hip, or forearm. It is commonly considered that this osteoporotic portion of the population has a faster bone mass loss, and interventions